However, according to the preclinical studies, Thymoquinone destabilizes the binding between HIF-1α and HSP90 and helps in pVHL-mediated polyubiquitination of HIF-1α protein, which is independent of prolyl hydroxylation in renal cancer cells [177]. This evidence concerns the gene HIF1A and renal carcinoma.